(lp0
S'Vanda Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial ... PR Newswire  - Feb 10, 2016 10, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc.  , today announced financial and operational results for the fourth quarter and full year ended December 31, 2015.'
p1
aS'Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial ... PR Newswire  - Jan 19, 2017 To participate in the conference call, please dial 1-888-771-4371  or 1-847-585-4405  and use passcode 44159815.'
p2
aS"Vanda Pharmaceuticals'  CEO Mihael Polymeropoulos on Q4 2016 Results ... Seeking Alpha - Feb 16, 2017 Welcome to the Q4 2016 Vanda Pharmaceuticals Inc. Earnings Conference Call. My name is Victoria and I will be your operator for today's call.Point72 Asset Management, LP Raises Stake in Vanda Pharmaceuticals, Inc. (VNDA ... - StreetInsider.comVanda Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial ... - Yahoo Finance"
p3
aS"Vanda Pharmaceuticals Reports Third Quarter 2016 Financial Results PR Newswire  - Nov 2, 2016 WASHINGTON, Nov. 2, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc.  , today announced financial and operational results for the third quarter ended September 30, 2016.Vanda Pharmaceuticals'  CEO Mihael Polymeropoulos on Q3 2016 Results ... - Seeking Alpha"
p4
aS"Kenneth Bate Joins the Board of Directors of Vanda Pharmaceuticals PR Newswire  - Dec 18, 2015 WASHINGTON, Dec. 18, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc.  , announced today that Kenneth Bate, an independent biotechnology industry consultant, has joined Vanda's Board of Directors."
p5
aS"Why Analysts put forward these two stocks: HollyFrontier Corporation (HFC ... The USA Commerce - Mar 27, 2017 Shares of HollyFrontier Corporation  dropped -1.44% to $26.65. During the trading on 03/24/2017, Company's stock ranged from $27.25 to $26.64."
p6
aS'Vanda Pharmaceuticals appoints Gian Piero Reverberi as Acting Chief Commercial ... PR Newswire  - Dec 17, 2015 WASHINGTON, Dec. 17, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc.   today announced that it has appointed Gian Piero Reverberi to the role of Senior Vice President, Acting Chief Commercial Officer and European General&nbsp;...'
p7
aS"Why to Keeping Eye on Gogo Inc. , Vanda Pharmaceuticals Inc. ? StockNewsJournal - Mar 22, 2017 Vanda Pharmaceuticals Inc. , at its latest closing price of $13.90, it has a price-to-book ratio of 4.74, compared to an industry average at 10.15.What's Happening To These Stocks?  Vanda Pharmaceuticals Inc. , Gray ... - Post AnalystYesterday Stock Trend Overview: Vanda Pharmaceuticals Inc.  - Is stories"
p8
aS"Vanda Pharmaceuticals Announces the Appointment of European General Manager PR Newswire  - Sep 8, 2015 8, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc.   today announced that it has named Gian Piero Reverberi as Vanda's Senior Vice President, European General Manager."
p9
aS"A Look at 2 Trending Stocks: Vanda Pharmaceuticals Inc. , General ... Post Analyst - 17 hours ago Vanda Pharmaceuticals Inc.  revenue totaled $38.39 million down -0.23% from the previous quarter. The good news is, sales may return to growth this quarter.Running Mover to Focus: Vanda Pharmaceuticals Inc.'s  stock price is ... - Hot Stocks Point"
p10
a.